Recovery treatment of COVID-19
Mesenchymal stem cells (MSCs) derived from the placenta in COVID-19 treatment
People around the world have faced SARS-COV-19 pandemic, which causes COVID-19.

There is no antiviral therapy, and vaccine has not been developed yet. Studies show that even patients, who were asymptomatic, have changes in lungs.
Effects of COVID-19:

immune system
causes a “cytokine storm” - a massive release of cytokines - cell hormones that destroy their own tissues, cause edema. Reduce protective functions due to a rapid decline in lymphocytes, cells that fight the virus.

respiratory system
causes pneumonia, due to the destruction of lung tissue leads to acute distress syndrome, respiratory failure.

organism as a whole
increases inflammatory processes, leads to exacerbation of chronic diseases, especially dangerous for people with cardiovascular, respiratory diseases, impaired liver function and metabolism, immunosuppression, oncology.
Scientists and doctors of Institute of Cell Therapy have developed a program to stabilize the immune system and restore patients who suffered from COVID-19. We were relying on our own half-century experience of using mesenchymal stem cells in the treatment of patients with various pathology and world studies in the field of stem cells (MSCs) effects on the fight against coronavirus infection and its complications. To date, 15 clinical trials have proven the effectiveness of this method, 50 - are to be successfully completed.
The effect of mesenchymal stem cells administration in COVID-19 treatment
-
increase of antiviral protection due to the properties of MSCs and an increase of the number of lymphocytes
-
reduction in the general inflammatory process in the body by lowering C-reactive protein, TNF-a
-
increase in the level of anti-inflammatory protein IL-10

Stem cell treatment ensures:

-
Immunomodulation - optimization of the protective response
-
Protects and improves lung function: restores alveoli, prevents fibrosis and respiratory failure, significantly reduces the risk of mortality
-
Protects other organs and tissues of the body, reduces the risk of non-specific complications

-
Improves blood supply to all organs and tissues, accelerates the recovery of the body and rehabilitation after a viral infection
-
After the treatment, shortness of breath is reducing, cough finishes faster, breathing improves, endurance during physical activity increases, the virus is no longer detected in the blood
Consultation
Call or write, and our consultant will give comprehensive answers to all your questions.
